Website & contact details
- Group website
- The site of this company’s group or brand.
Bioscript Group Limited
- Incorporated
- 14 April 2015 (11 years)
- Industry
- Activities of other holding companies n.e.c. (64209)
- Directors
- Owned by
- Accounts type
- Full
- Region
- North West
- Address
- Suite AGreenway House Larkwood WayTytherington Business ParkMacclesfieldSK10 2XR
Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 6 February 2027
- Last conf. stmt
- 23 January 2026
Charges
- Total
- 3
- Outstanding
- 3
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 15 February 2024
British
Born December 1984 (41)
Director · Appointed 15 February 2024
British
Born September 1973 (53)
Officer history (5 former)
19 April 2024
19 April 2024
15 February 2024
15 February 2024
18 September 2019
12 September 2017
Resigned Medley, Andrew John as Secretary
14 April 2015
14 April 2015
14 April 2015
Appointed Medley, Andrew John as Secretary
14 April 2015
14 April 2015
14 April 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 2 March 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 13216692
Former controllers (1)
2 March 2021
Group structure 13 shown
Ownership group derived from the Companies House PSC register
Bioscript Limited Owns 75–100% of shares
Azimuth Pharma Limited Owns 75–100% of shares
Fortis Pharma Consulting Limited Owns 75–100% of shares
Bioscript Group Limited This company Owns 75–100% of shares
Bioscript Stirling Limited Owns 75–100% of shares
Medologie Limited Owns 75–100% of shares
Enzyme Communications Ltd Owns 75–100% of shares
Meridian Healthcomms Holdings Limited Owns 75–100% of shares
Cancer Communications and Consultancy Limited Owns 75–100% of shares
Meridian Healthcomms Limited Owns 75–100% of shares
Triducive Partners Limited Owns 75–100% of shares
Valid Insight Ltd Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 30 September 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £81,186
- Cash
- £106
- Profit Before Tax
- (£10)
- Debt Ratio
- 27%
- Current Ratio
- 0.3x
- Return on Equity
- -0%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £101,182 | £101,182 | £101,182 | £101,182 | £22,182 | £22,182 |
| Current Assets | £9,513 | £9,423 | £9,430 | £9,496 | ||
| Cash | £106 | £16 | £23 | £89 | ||
| Creditors (< 1 year) | £29,509 | £29,409 | £29,309 | £21,787 | £21,687 | £21,687 |
| Net Current Assets | (£19,996) | (£19,986) | (£19,879) | (£12,291) | (£21,687) | (£21,687) |
| Net Assets | £81,186 | £81,196 | £61,553 | £69,141 | £495 | £495 |
| Shareholder Funds | £81,186 | £81,196 | £61,553 | £69,141 | £495 | £495 |
Filings 67
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 June 2026 | Full accounts | 30 September 2025 | ||
| 1 May 2026 | Registration of a charge | |||
| 5 February 2026 | Confirmation statement with no updates | 23 January 2026 | ||
| 27 June 2025 | Full accounts | 30 September 2024 | ||
| 7 February 2025 | Director's details changed |
Some other companies at this address
Other companies in this industry
Rochester
Halifax
Northampton
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →